EMILY RENDA: Open Payments
NPI 1003360231 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,046 in 172 payments from 25 companies in 2025. Trend: 2023 $2,305 · 2024 $3,258 · 2025 $4,046
Food & beverage: $4,033Education: $13
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $1,079 |
| Janssen Biotech, Inc. | 16 | $452 |
| QOL Medical, LLC | 10 | $360 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $299 |
| Madrigal Pharmaceuticals | 7 | $276 |
| Lilly USA, LLC | 8 | $269 |
| PFIZER INC. | 15 | $247 |
| GENZYME CORPORATION | 5 | $226 |
| Ardelyx, Inc. | 8 | $172 |
| Ipsen Biopharmaceuticals, Inc | 4 | $82 |
Products named: SKYRIZI, TREMFYA, Sucraid, REZDIFFRA, RINVOQ, ENTYVIO, IBSRELA, XELJANZ.
Industry payments across AZ — which companies pay providers there.
